SecBot SecBot
144 ·Filed Jun 1, 2026

ANAB

ANAPTYSBIO, INC
BEARISH
Impact 5/10
Horizondays Processed5mo ago SEC0001950047-26-005454
Form 144, notice of proposed sale of securities
Actionable Insight ▼ Bearish

The officer has been a consistent seller over the past two weeks, disposing of over 80,000 shares. While the Form 144 amount is modest relative to market cap, the pattern of sustained selling by an insider warrants monitoring for any upcoming negative catalyst or earnings miss.

DirectionBearish
Confidencemedium
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$51.26
T+0 close · Jun 1, 2026 · via day close
Latest settled
+13.15%
T+60 · $58.00
Vs SPY
+12.03%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 2 $51.26entry
  2. T+1 · 6mo ago −0.04%α +0.68% · $51.24
  3. T+5 · 5mo ago +0.72%α +3.69% · $51.63
  4. T+20 · 5mo ago +27.64%α +29.21% · $65.43
  5. T+60 · 3mo ago +13.15%α +12.03% · $58.00

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Dennis Mulroy, an officer of AnaptysBio, filed a Form 144 on June 1, 2026, indicating intent to sell 7,691 shares of common stock valued at approximately $404,340. This follows a series of recent open-market sales by Mulroy totaling over 80,000 shares in the prior two weeks, suggesting a pattern of insider monetization.

Key Facts

  • Officer Dennis Mulroy filed Form 144 to sell 7,691 shares valued at ~$404,340.
  • Mulroy has sold 80,731 shares in open-market transactions from May 15 to May 29, 2026, totaling ~$4.8M.
  • The proposed sale is via Morgan Stanley Smith Barney LLC.
  • Shares were acquired via stock option exercise on June 1, 2026.
  • AnaptysBio has a market cap of $1.6B and 89% analyst bullish consensus.

Financial Impact

Proposed sale of $404K; cumulative recent sales by officer exceed $5M.

insider selling volume

Risk Factors

  • Insider selling ahead of potential negative news or clinical data.
  • Further unannounced sales may pressure the stock.
  • Pattern may signal lack of confidence in near-term prospects despite bullish analyst consensus.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (18 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-005454
Document: 0001950047-26-005454-index.html0001950047-26-005454
Document: 0001950047-26-005454.txt0001950047-26-005454

Track record

28 reports on ANAB

Performance horizon

9 of 18 bullish or bearish reports moved the stock their way by T+1. Best: +41.26% at T+60 after the Mar 3, 2026 report. 12 of 18 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $46.25 Now $45.73 −1.12% settles Nov 17
  2. Nov 12, 20264d ago Press Release Bearish 4/10 Entry $46.25 to $45.73 Now $45.73 +1.12% ▲ +1.12% −0.79% vs SPY
  3. Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $46.45 to $47.97 Now $45.73 −1.55% ▲ +3.27% +0.91% vs SPY
  4. Sep 21, 20268w ago Press Release Neutral 5/10 Entry $53.92 to $50.77 Now $45.73 −15.19% ▼ −5.84% −5.12% vs SPY
  5. Aug 12, 202613w ago Institutional Cluster Bullish 5/10 Entry $56.02 to $58.47 Now $45.73 −18.37% ▲ +4.37% +4.57% vs SPY
  6. Jun 29, 202620w ago 144 Bearish 6/10 Entry $67.50 to $65.43 Now $45.73 +32.25% ▲ +3.07% +2.93% vs SPY
  7. Jun 29, 202620w ago DEFA14A Neutral 2/10 Entry $67.50 to $65.43 Now $45.73 −32.25% ▼ −3.07% −2.93% vs SPY
  8. Jun 26, 202620w ago 144 Bearish 6/10 Entry $65.97 to $67.50 Now $45.73 +30.68% ▼ −2.32% −1.54% vs SPY
  9. Jun 22, 202621w ago 8-K Neutral 2/10 Entry $59.43 to $58.48 Now $45.73 −23.05% ▼ −1.60% −1.55% vs SPY
  10. Jun 17, 202621w ago 144 Bearish 5/10 Entry $57.51 to $59.99 Now $45.73 +20.48% ▼ −4.31% −4.63% vs SPY
Showing 10 of 28

US Market Status

Market Closed · Opens in 6h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 1, 2026